There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Trevi Therapeutics (TRVI – Research Report) and Walgreens Boots Alliance (WBA – Research Report) with bullish sentiments.
Trevi Therapeutics (TRVI)
Needham analyst Serge Belanger maintained a Buy rating on Trevi Therapeutics today and set a price target of $8.00. The company’s shares closed last Wednesday at $3.54, close to its 52-week high of $3.58.
According to TipRanks.com, Belanger is a 3-star analyst with an average return of
Trevi Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $8.00.
See the top stocks recommended by analysts >>
Walgreens Boots Alliance (WBA)
J.P. Morgan analyst Lisa Gill maintained a Buy rating on Walgreens Boots Alliance today. The company’s shares closed last Wednesday at $21.09, close to its 52-week low of $19.68.
According to TipRanks.com, Gill is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Walgreens Boots Alliance with a $24.67 average price target, implying a 19.6% upside from current levels. In a report issued on March 14, TD Cowen also assigned a Buy rating to the stock with a $37.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TRVI:
